Ginkgo and OpenAI Lab Cuts Protein Synthesis Costs
Ginkgo Bioworks, in collaboration with OpenAI, has developed an AI-driven autonomous laboratory that ran 36,000 biological experiments. The system, which leverages GPT-5 and automation, reportedly reduced the cost of cell-free protein synthesis by 40%.
- The AI-driven system reduced the cost of producing a benchmark protein, superfolder Green Fluorescent Protein (sfGFP), to $422 per gram, representing a 40% overall cost reduction and a 57% improvement in reagent costs specifically. This was achieved over six iterative cycles, which included testing 36,000 different reaction compositions and generating nearly 150,000 data points. - This collaboration paired OpenAI's GPT-5 reasoning model with Ginkgo's "Foundry" infrastructure, which utilizes reconfigurable automation carts and Catalyst automation software to create a closed-loop system for designing, executing, and analyzing experiments. The AI was given internet access and data analysis software, allowing it to operate like an experimental scientist with minimal human intervention. - Unlike AI models that predict protein structures, this approach treats protein sequences as a language to be optimized. This method of applying Large Language Models (LLMs) to the "language of proteins" allows for the generation of novel, functional proteins by learning the intricate patterns within amino acid sequences from massive databases. - The resulting AI-optimized cell-free reaction mix is being made commercially available through Ginkgo's reagent store, demonstrating a direct path from AI-driven experimentation to a commercial product. This aligns with Ginkgo's broader business model of providing its automated lab infrastructure and engineered organisms as a service to partners. - Cell-free protein synthesis (CFPS) offers advantages over traditional cell-based methods by removing the complexities of cell growth and maintenance, which is particularly useful for producing toxic proteins or for applications requiring rapid and reproducible results. The open nature of CFPS allows for easier manipulation of the reaction environment, making it suitable for high-throughput screening and optimization. - The integration of AI into biomanufacturing is a broader industry trend aimed at enhancing efficiency, improving quality control, and reducing human error. AI algorithms are being used to optimize process parameters, accelerate the development of new cell lines, and automate regulatory compliance documentation. - Ginkgo's business model is centered on its Foundry and Codebase, providing research and development services through collaboration and license agreements. The company generates revenue from upfront R&D fees, milestone payments, and royalties on the commercial success of the custom-designed microbes developed for its clients.
